The Society responded to the Science communication inquiry of the House of Commons Science and Technology Committee. The inquiry looked into how the Government, scientists, the media…
A review of nine observational studies found evidence supporting an increased risk of heart attacks in patients taking antipsychotic drugs. The review expands previous knowledge by demonstrating an…
In January 2016, the Society was approached to contribute to Sir William Wakeham's review of STEM degree provision and graduate employability. The review looked at the provision of…
Professor David Webb, President of the British Pharmacological Society, comments, “The British Pharmacological Society welcomes Sir William Wakeham’s review of STEM degree provision and graduate…
Patient engagement is the key to unlocking the pressing issue of how the UK can afford its increasing expenditure on medicines – according to speakers at a public event held by the British…
Medicines that carry warnings about sleep disturbances do not seem to contribute to the amount of sleep disturbances in the general population, according to new ‘real world’ research. The findings,…
It is with great pleasure that the British Pharmacological Society announces the winners of the Society’s most recently-judged prizes and awards. Many of these prizes will be officially awarded as…
As many members will already be aware, the majority of voters in yesterday’s referendum on the UK’s membership of the European Union (EU) have chosen to leave. In light of this decision, it will…
Zinc acetate lozenges may reduce the duration of the common cold by nearly 3 days, according to a recent analysis in the British Journal of Clinical Pharmacology.Among 199 patients with the common…
A new, updated and restructured Competency Framework for all Prescribers has been published today (14 July) by the Royal Pharmaceutical Society (RPS) after collaboration with the British…
